Veracyte VCYT International — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Veracyte’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veracyte's international — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Veracyte's international — total revenue?
- Veracyte (VCYT) reported international — total revenue of $5.14M in Q4 2025.
- How has Veracyte's international — total revenue changed year-over-year?
- Veracyte's international — total revenue decreased by 7.6% year-over-year, from $5.56M to $5.14M.
- What is the long-term trend for Veracyte's international — total revenue?
- Over 4 years (2021 to 2025), Veracyte's international — total revenue has grown at a 2.6% compound annual growth rate (CAGR), from $18.53M to $20.55M.
- What does international — total revenue mean?
- This metric represents the total gross revenue generated from sales and services provided to customers located outside of the company's primary domestic market. It serves as a key indicator of the company's global footprint and its ability to successfully commercialize its diagnostic products in international regulatory environments. Tracking this figure helps investors assess the diversification of revenue streams and the effectiveness of global market expansion strategies.